Frontlight ResearchEarly access
Trial site
Instituto Medico Especializado Alexander Fleming
- 2running trials
- 1closed trial
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Phase
- Phase 33 trials
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- EMD Serono Research & Development Institute, Inc.1 trial
- Incyte Corporation1 trial
- Pierre Fabre Medicament1 trial
Running trials
Recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026